This study investigates how blood cell growth patterns (known as clonal hematopoiesis) affect heart health after treatment for Hodgkin lymphoma—a type of cancer. Cancer treatments, especially when given at a young age, can sometimes lead to heart health problems later. By studying these blood cell growth patterns, doctors hope to predict who might face heart issues after their treatment. This way, they can keep a closer eye on these patients to catch any heart problems early.
Participants will have their blood samples collected, complete some surveys, and have a cardiac MRI (a special heart scan) done. The study is observational, meaning it just observes without changing any treatment.
- Study Duration: It doesn't specify how long, but participants must be at least 7 years old and have finished cancer treatment at least 2 years ago.
- Participation: Participants must be able to have a cardiac MRI without any sedation.
- Eligibility: Patients must have a history of Hodgkin lymphoma diagnosed between ages 2 and 22 and have completed all cancer treatments.
How understandable was the trial content above?
Hard to understand
Easy to understand